Buy BLGO by Nov 7, 2026.

CEO Dennis Calvert just accepted stock instead of cash for salary and expenses at these levels. More importantly, those shares are locked until BioLargo reaches **$40M in consolidated revenue** or a **$300M market cap** — roughly **5x current annual revenue** and nearly **9x today’s \~$35M valuation**. That is serious alignment: he does not truly get paid unless shareholders win big too. I’ll be honest: it has been frustrating. My position was worth more than **$1M higher** at one point. But …